SOSV is a global venture capital firm founded in 1995 and headquartered in Princeton, New Jersey. Specializing in seed-to-growth stage investments, SOSV operates multiple accelerator programs worldwide, including HAX for hardware, IndieBio and RebelBio for life sciences, Chinaccelerator and MOX for cross-border internet ventures, Food-X for innovative food solutions, and dlab for blockchain technology. The firm focuses on investments in revolutionary deep technologies aimed at improving human and planetary health, as well as cross-border markets, particularly in Asia. SOSV invests in approximately 150 startups annually, providing support through its resources to accelerate product development and scaling. Over its two-decade history, SOSV has established a strong reputation, consistently ranking among the top venture capital firms globally.
Canaery is building a neural interface for analyzing an object’s scent fingerprint to identify dangerous compounds at places like ports and inspection points without (or in addition to) x-rays or cameras.
Pannex Therapeutics is a scientifically-based pharmaceutical company that develops new drugs to treat chronic musculoskeletal pain. was founded in 2020.
Alternative Plants is a biotech start-up that establishes plant stem cell cultures for effective, consistent and sustainable production of cosmetic active ingredients. Our focus is on medicinal plants that are difficult to grow, are rare or even endangered, so our plant stem cell culture technology is the only way to access the valuable substances that they produce. Our current focus is on cosmetic active ingredients market. Our clients are cosmetic manufacturers that use our plant stem cell derived active substances as key active ingredients in their products. In the same time we clearly see that with our technology we can later expand to other markets as functional foods, medical devices and pharma as well.
Ceragen is a biotechnology company based in Kitchener, Ontario, focused on enhancing agricultural productivity through plant microbiome engineering. The company specializes in precision microbiome engineering, offering inoculant products specifically designed for controlled environment agriculture. These products aim to provide farmers with natural solutions that enhance crop yields, allowing them to grow more food in smaller spaces. By improving plants' resilience to environmental stressors, Ceragen's innovations support sustainable farming practices and contribute to the efficient use of land resources, addressing the growing need to feed the global population.
California Cultured is a food company based in Davis, California, that specializes in producing sustainable, lab-grown cocoa through advanced cellular agriculture techniques. Founded in 2020, the company aims to create cocoa that is less bitter and requires less sugar, enhancing the taste while promoting health benefits. By stimulating cocoa cells with common food ingredients, California Cultured ensures the growth of premium-quality cocoa without the ethical and environmental issues associated with traditional cocoa production, such as slavery and deforestation. This innovative approach allows customers to enjoy delicious cocoa products that are both sustainable and socially responsible.
Pannex Therapeutics is a scientifically-based pharmaceutical company that develops new drugs to treat chronic musculoskeletal pain. was founded in 2020.
Ceragen is a biotechnology company based in Kitchener, Ontario, focused on enhancing agricultural productivity through plant microbiome engineering. The company specializes in precision microbiome engineering, offering inoculant products specifically designed for controlled environment agriculture. These products aim to provide farmers with natural solutions that enhance crop yields, allowing them to grow more food in smaller spaces. By improving plants' resilience to environmental stressors, Ceragen's innovations support sustainable farming practices and contribute to the efficient use of land resources, addressing the growing need to feed the global population.
Ceragen is a biotechnology company based in Kitchener, Ontario, focused on enhancing agricultural productivity through plant microbiome engineering. The company specializes in precision microbiome engineering, offering inoculant products specifically designed for controlled environment agriculture. These products aim to provide farmers with natural solutions that enhance crop yields, allowing them to grow more food in smaller spaces. By improving plants' resilience to environmental stressors, Ceragen's innovations support sustainable farming practices and contribute to the efficient use of land resources, addressing the growing need to feed the global population.
Canaery
Seed Round in 2021
Canaery is building a neural interface for analyzing an object’s scent fingerprint to identify dangerous compounds at places like ports and inspection points without (or in addition to) x-rays or cameras.
Canaery
Convertible Note in 2021
Canaery is building a neural interface for analyzing an object’s scent fingerprint to identify dangerous compounds at places like ports and inspection points without (or in addition to) x-rays or cameras.
California Cultured is a food company based in Davis, California, that specializes in producing sustainable, lab-grown cocoa through advanced cellular agriculture techniques. Founded in 2020, the company aims to create cocoa that is less bitter and requires less sugar, enhancing the taste while promoting health benefits. By stimulating cocoa cells with common food ingredients, California Cultured ensures the growth of premium-quality cocoa without the ethical and environmental issues associated with traditional cocoa production, such as slavery and deforestation. This innovative approach allows customers to enjoy delicious cocoa products that are both sustainable and socially responsible.
California Cultured is a food company based in Davis, California, that specializes in producing sustainable, lab-grown cocoa through advanced cellular agriculture techniques. Founded in 2020, the company aims to create cocoa that is less bitter and requires less sugar, enhancing the taste while promoting health benefits. By stimulating cocoa cells with common food ingredients, California Cultured ensures the growth of premium-quality cocoa without the ethical and environmental issues associated with traditional cocoa production, such as slavery and deforestation. This innovative approach allows customers to enjoy delicious cocoa products that are both sustainable and socially responsible.
Mushroom Cups d.o.o. is a company based in Solin, Croatia, specializing in the production of organic coffee infused with mushrooms. Founded in 2016, it offers two primary instant coffee blends, Go Sharp and Go Fresh, designed to enhance the coffee experience while reducing typical side effects associated with caffeine. The company employs a process that includes harvesting, drying, grinding, mixing, and extracting to create its unique products. Mushroom Cups aims to provide consumers with a beverage that not only boosts energy and productivity but also supports mental performance and overall wellness through the incorporation of super-food mushroom extracts. Additionally, the company's products are available for purchase online, expanding their reach to health-conscious coffee drinkers.
11 Biomics LLC develops biological therapeutics for the cannabis industry. It offers small and large scale treatment and protection against fungal and bacterial diseases in cannabis and hemp. The company is based in Albuquerque, New Mexico.
NEUROCARRUS INC, a biotechnology company, develops a novel drug delivery technology to disrupt pain signals without addiction-forming medications or disruption of muscular control. The company was incorporated in 2017 and is headquartered in Lincoln, Nebraska.
Hyasynth Bio is a Montreal-based company that specializes in the production of natural cannabinoid compounds. It focuses on developing innovative solutions for researchers, healthcare professionals, and patients dealing with conditions such as multiple sclerosis, epilepsy, Alzheimer's disease, chronic pain, inflammation, and muscular dystrophy. By leveraging a combination of traditional and modern biological technologies along with computational analysis, Hyasynth Bio aims to create effective drugs for a wide range of diseases. The company utilizes a scalable platform based on engineered microbes to enhance its drug development process, effectively addressing the needs of the medical community.
Canuevo Biotech Inc. specializes in the development of cannabinoid (CBD) formulations and innovative drug delivery mechanisms aimed at improving efficacy for various medical conditions. Founded in 2017 and based in Fredericton, Canada, the company designs custom vessels for encapsulated CBD, producing a range of products including skin creams and tablets. Canuevo's offerings target neurological disorders such as epilepsy and seizures, movement disorders like Parkinson’s and Alzheimer’s, chronic inflammation, and other conditions including irritable bowel syndrome and support for opiate dependency. The company addresses the challenges of standardization and acceptance of cannabis-derived medications within the medical and regulatory spheres, selling its products online to reach a broader audience.
Alternative Plants is a biotech start-up that establishes plant stem cell cultures for effective, consistent and sustainable production of cosmetic active ingredients. Our focus is on medicinal plants that are difficult to grow, are rare or even endangered, so our plant stem cell culture technology is the only way to access the valuable substances that they produce. Our current focus is on cosmetic active ingredients market. Our clients are cosmetic manufacturers that use our plant stem cell derived active substances as key active ingredients in their products. In the same time we clearly see that with our technology we can later expand to other markets as functional foods, medical devices and pharma as well.
Hyasynth Bio is a Montreal-based company that specializes in the production of natural cannabinoid compounds. It focuses on developing innovative solutions for researchers, healthcare professionals, and patients dealing with conditions such as multiple sclerosis, epilepsy, Alzheimer's disease, chronic pain, inflammation, and muscular dystrophy. By leveraging a combination of traditional and modern biological technologies along with computational analysis, Hyasynth Bio aims to create effective drugs for a wide range of diseases. The company utilizes a scalable platform based on engineered microbes to enhance its drug development process, effectively addressing the needs of the medical community.
Hyasynth Bio is a Montreal-based company that specializes in the production of natural cannabinoid compounds. It focuses on developing innovative solutions for researchers, healthcare professionals, and patients dealing with conditions such as multiple sclerosis, epilepsy, Alzheimer's disease, chronic pain, inflammation, and muscular dystrophy. By leveraging a combination of traditional and modern biological technologies along with computational analysis, Hyasynth Bio aims to create effective drugs for a wide range of diseases. The company utilizes a scalable platform based on engineered microbes to enhance its drug development process, effectively addressing the needs of the medical community.
Hyasynth Bio is a Montreal-based company that specializes in the production of natural cannabinoid compounds. It focuses on developing innovative solutions for researchers, healthcare professionals, and patients dealing with conditions such as multiple sclerosis, epilepsy, Alzheimer's disease, chronic pain, inflammation, and muscular dystrophy. By leveraging a combination of traditional and modern biological technologies along with computational analysis, Hyasynth Bio aims to create effective drugs for a wide range of diseases. The company utilizes a scalable platform based on engineered microbes to enhance its drug development process, effectively addressing the needs of the medical community.
Hyasynth Bio is a Montreal-based company that specializes in the production of natural cannabinoid compounds. It focuses on developing innovative solutions for researchers, healthcare professionals, and patients dealing with conditions such as multiple sclerosis, epilepsy, Alzheimer's disease, chronic pain, inflammation, and muscular dystrophy. By leveraging a combination of traditional and modern biological technologies along with computational analysis, Hyasynth Bio aims to create effective drugs for a wide range of diseases. The company utilizes a scalable platform based on engineered microbes to enhance its drug development process, effectively addressing the needs of the medical community.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.